UK Healthcare Waiting Pressures Beyond the Elective List

14 Oct 2026 | Altin Biba

| Share with

NHS Corridor Coordination and Care - Blog 1

Healthcare waiting pressures extend well beyond the headline elective list. Patients may be waiting for a first assessment, an investigation, a cancer diagnosis, psychological treatment or support that helps them function at home. These waits involve different services and clinical risks, but they can intersect in the same patient’s life.

For NHS leaders, that creates a demanding balance. Progress against a national target matters, while demand continues to arrive through services whose pressures are less visible in the main elective figures. Understanding recovery requires attention to where patients are waiting and what the next stage of care involves.

This review draws on evidence available on 2 October 2026 across England, Scotland, Wales and Northern Ireland. Reporting periods vary, and the measures cannot be combined into a UK patient total. The evidence provides a broader account of service demands and gaps in national visibility.

Elective recovery is progressing unevenly

England’s July referral-to-treatment list contained approximately 7.33 million pathways. Some 65.4% were within 18 weeks, compared with 61.3% a year earlier, while 111,379 exceeded 52 weeks. Improvement in access therefore coexists with a substantial remaining backlog. These are pathways: a person awaiting care for more than one condition can appear more than once. [1,2]

Scotland reported 506,512 ongoing first-outpatient waits and 157,485 inpatient or day-case waits at the end of August. Its outpatient list rose for a fifth month, despite being smaller than a year earlier. Wales recorded around 709,700 referral-to-treatment pathways in July, with a further rise indicated by provisional August figures. Northern Ireland’s June lists contained 504,537 first-outpatient waits and 81,223 admission waits; 53.7% of outpatient waits exceeded a year. [3–5]

These figures describe different parts of care. England and Wales measure open referral-to-treatment pathways, with differences in coverage. Scotland and Northern Ireland also publish separate stages. A first-outpatient queue contains patients whose diagnosis and treatment requirements may still need to be established. An admission queue describes a later stage, although individual circumstances and readiness for treatment vary. Their demands on services are different. [1]

A service can treat patients who have waited exceptionally long while new referrals accumulate. Conversely, a smaller list does not reveal, on its own, how much care was delivered or why other pathways closed. NHS England reports removals separately because list movement involves more than treatment activity. [2,24]

The interpretation also depends on recording. England estimates missing submissions; Scotland has changed waiting-time calculations; Northern Ireland’s encompass data are not directly comparable with legacy systems. These qualifications belong alongside the performance story, rather than being treated as minor footnotes. [2,3,5]

Diagnostics and cancer expose pressure across the pathway

Diagnostic waits are a substantial pressure in their own right. England’s July collection for 15 tests recorded around 1.92 million waits, with 23.1% at six weeks or more. Scotland reported 107,803 waits for eight key tests at the end of June, with 72% within six weeks. Wales recorded around 118,700 diagnostic pathways in July, including approximately 37,500 beyond eight weeks. Northern Ireland recorded 231,145 diagnostic waits in June, with 61% beyond nine weeks. Different tests and thresholds prevent a direct ranking. [4–7]

These collections do not measure every interval between referral and a clinical decision. Completing a test may still leave reporting, discussion of findings or further investigation outstanding. The operational significance is that a patient’s progress depends on the sequence of work, even when an individual appointment has taken place. The published totals do not identify the limiting step in a particular service.

Cancer measures make those different stages more explicit. Cancer Research UK’s analysis of England’s July figures reports 79.3% diagnosed or having cancer ruled out within 28 days, against an 80% target, and 71.2% starting treatment within 62 days, against 85%. Scotland’s quarter ending June recorded 73.6% within its 62-day standard and 94.8% within 31 days of a decision to treat; both standards are 95%. [8,9]

Wales reported 60.1% starting treatment within 62 days of first suspicion in July. Northern Ireland’s newly published June-quarter figures recorded 28.4% within 62 days following an urgent GP referral and 88.7% within 31 days of a treatment decision. The clock starts, eligible cohorts and treatment definitions differ. The percentages show pressure within each national framework; they do not support a simple comparison of like-for-like pathways. [4,10]

The contrast between referral-to-treatment and decision-to-treatment performance is informative, but it cannot isolate diagnostic delay: the cohorts differ, and earlier stages include more than testing. It does show why a single treatment measure cannot describe the whole cancer pathway. Clinical urgency adds another dimension, because elapsed time alone cannot establish the consequences of a delay for an individual patient.

Mental health and neurodevelopment need their own account

Mental health access cannot be represented by one waiting list. England’s July headline of 2.41 million people with an open mental health referral includes people already receiving care. Calling all of them patients waiting for treatment would misrepresent the workload and the access problem. [11]

The NHS Alliance’s analysis of the three months to July reports a median of 297 days from referral for children and young people still awaiting a first mental health contact. It also reports 191,007 adults with serious mental illness still awaiting a second community mental health contact in that period. These are specific contact measures, rather than a guarantee that assessment or a therapeutic course is complete. They cannot be added to elective or neurodevelopmental totals. [11]

England’s Talking Therapies figures offer a different view. Among referrals completing a course in July, 83.8% had accessed treatment within six weeks, above the 75% standard. That measure looks back at the initial wait of people who finished treatment; it does not describe everybody still waiting or the interval between subsequent sessions. [12]

Scotland’s June-quarter figures show 90.9% of children and young people starting CAMHS treatment within 18 weeks, against a 90% standard. Psychological therapies, covering all ages, recorded 80.7% against the same standard. Missing submissions affect the CAMHS total, and both series use adjusted waits. In Wales, June local primary mental health figures recorded 82.7% of adult assessments within 28 days and 87.5% for under-18s. This covers a defined service, not every specialist mental health pathway. [13–15]

Northern Ireland illustrates a further challenge: its official CAMHS publication remains paused pending quality assurance of the new data source, with March 2025 listed as the current release. That is a gap in timely national visibility, not evidence that the underlying pressure has disappeared. [16]

Neurodevelopmental access requires separate interpretation. England recorded 294,792 patients with an open suspected-autism referral in June; 86.8% had been open for at least 13 weeks. This is not a count solely of people awaiting their first assessment. Community paediatric autism activity is excluded, and a missing submission drove the apparent monthly fall. [17]

England’s ADHD management information also uses proxies that include other conditions and some patients already diagnosed. People can appear in both contributing datasets. Scotland explicitly excludes separate neurodevelopmental pathways from its CAMHS collection, while Wales is changing its children’s neurodevelopmental reporting. These boundaries matter: success in a published mental health standard cannot be assumed to describe access to autism or ADHD assessment. [13,18,19]

Community care and access before referral remain important

Community services are part of the waiting-pressure picture. The NHS Alliance reports an England community waiting list of approximately 1.24 million in July. Among children and young people, 26.7% had waited at least 52 weeks. The figure covers reported services and carries collection limitations; it is not a deduplicated count of additional people beyond every other NHS list. [20]

Wales recorded around 65,800 therapy pathways in July, its highest reported total, with approximately 6,800 beyond 14 weeks. Scotland’s latest allied health professional musculoskeletal release recorded 75,128 patients waiting at the end of March. That collection covers physiotherapy, occupational therapy, podiatry and orthotics for musculoskeletal conditions, rather than all community care. No equivalent current, comprehensive Northern Ireland community total was verified in this review. [4,21]

The significance extends beyond another queue. Rehabilitation and community support relate to independence, recovery and the practical ability to manage everyday life. They also involve different clinical skills from those required for a diagnostic procedure or an inpatient admission. Describing all waiting pressure as an acute elective capacity problem would miss these distinct demands.

Primary care and dentistry reveal a further boundary: some people experience difficulty accessing care before a hospital referral or a formal waiting-list entry exists. Scotland’s 2025–26 experience survey found 78% could contact their GP practice easily in the way they wanted. That is a patient-experience measure, not a count of people awaiting appointments. It supplies a different kind of evidence about access. [22]

Dental measures are similarly varied. England’s 2026 survey reported 81.5% could obtain an NHS dental appointment the last time they tried; this does not represent everyone who might need care. Scotland reported 95.1% registered with an NHS dentist in March, while 62.1% of registered patients had participated in NHS dental care within two years. Registration and recent use are different measures, and neither establishes a waiting-list total. [23,25]

Wales’ dental access portal provides a route for recording people seeking NHS dental care, while its annual statistics describe treatment received. This review does not establish a comparable four-nation dental queue. Maintaining that distinction leaves room for unmet need without assigning an unsupported number to it. [26,27]

The full pressure includes what happens between measures

The broader evidence describes a set of connected demands, measured with uneven coverage. Patients can need more than one service, and one pathway can involve several teams. National totals cannot show whether each handover happens promptly or whether the next service has capacity when an earlier stage is completed.

There are also waits after first treatment. England’s recording guidance distinguishes clinically planned follow-up and surveillance from active referral-to-treatment waits. Absence from the headline list therefore does not establish that every subsequent care requirement is timely. Planned dates and overdue follow-up require their own interpretation. [28]

Urgent and emergency waits, and delays leaving hospital, sit alongside planned-care pressures. They use different clocks and denominators. Wales reported just under 1,400 discharge pathway delays in its August snapshot. This is evidence of another access and flow pressure, although the figure cannot quantify its effect on elective performance or identify the contribution of individual community or social care services. [4]

The national releases also cannot, by themselves, quantify unmet need among people who have not reached referral, establish the clinical condition of everyone waiting, or attribute harm to a particular delay. These limits are material to understanding the leadership challenge. Published performance, patients’ needs and the work required to progress care overlap, but none is a complete substitute for the others.

For leaders, the competing demands are therefore more specific than the headline totals suggest. Different cohorts need different assessment, treatment and onward-care resources; long waits coexist with urgent clinical priorities and continuing new demand.

Recovery through the whole patient journey

The UK’s healthcare waiting pressures encompass elective assessment and treatment, diagnostics, cancer, mental health, neurodevelopment and community care, together with access difficulties that may never become a conventional hospital waiting-list entry. Progress is real in parts of this picture, but it cannot be generalised across services or stages.

A credible account of recovery therefore connects the figures to the care they describe. It recognises the value of shorter waits, the demands still arriving and the clinical work that remains after an appointment or a target is achieved. That is the context in which NHS leaders are making decisions: multiple legitimate needs, finite resources and responsibility for patients whose journeys extend beyond any single reported measure.